- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有116家主力机构披露2024-06-30报告期持股数据，持仓量总计1.19亿股，占流通A股58.21%
- 波段诊断：
-
技术面诊股
诊断结果：2.7技术面打败了13%的股票
技术面评分前10的股票
近期的平均成本为13.78元。
平均成本
近期的平均成本为13.78元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"13.78","date":1732092549,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2024.11.21","stock":"-1.08","trade":"-0.44","ind":"0.07"},{"date":"2024.11.20","stock":"2.66","trade":"2.72","ind":"0.66"},{"date":"2024.11.19","stock":"4.73","trade":"2.39","ind":"0.67"},{"date":"2024.11.18","stock":"-3.87","trade":"-3.50","ind":"-0.21"},{"date":"2024.11.15","stock":"-2.04","trade":"-3.11","ind":"-1.45"},{"date":"2024.11.14","stock":"-4.53","trade":"-3.97","ind":"-1.73"},{"date":"2024.11.13","stock":"-2.84","trade":"-1.49","ind":"0.51"},{"date":"2024.11.12","stock":"-1.01","trade":"1.61","ind":"-1.39"},{"date":"2024.11.11","stock":"4.12","trade":"2.97","ind":"0.51"},{"date":"2024.11.08","stock":"0.35","trade":"0.47","ind":"-0.53"},{"date":"2024.11.07","stock":"3.63","trade":"2.80","ind":"2.57"},{"date":"2024.11.06","stock":"-1.57","trade":"0.63","ind":"-0.09"},{"date":"2024.11.05","stock":"4.87","trade":"3.90","ind":"2.32"},{"date":"2024.11.04","stock":"1.99","trade":"2.62","ind":"1.17"},{"date":"2024.11.01","stock":"-0.30","trade":"-2.50","ind":"-0.24"},{"date":"2024.10.31","stock":"-3.94","trade":"0.69","ind":"0.42"},{"date":"2024.10.30","stock":"-0.44","trade":"-2.07","ind":"-0.61"},{"date":"2024.10.29","stock":"-4.18","trade":"-2.51","ind":"-1.08"},{"date":"2024.10.28","stock":"-0.28","trade":"2.57","ind":"0.68"},{"date":"2024.10.25","stock":"11.11","trade":"4.70","ind":"0.59"},{"date":"2024.10.24","stock":"-0.69","trade":"-0.70","ind":"-0.68"}]
药康生物,上证指数,医疗服务指数
压力支撑
该股压力位为13.77元，支撑位为13.50元。
[{"text":"\u538b\u529b\u4f4d","value":"13.77","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.50","date":1732118400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.3资金面打败了90%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月21日 20:31
| 机构今日流向(万元) | -1048.65 | 机构5日流向(万元) | -5328.41 |
| 机构10日流向(万元) | -14991.37 | 机构20日流向(万元) | -8125.28 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少260.21万股，其中基金净增仓9家，主力净减仓30家，暂未发现中长期投资价值。
截止2024-06-30，共116家主力机构（基金109家，一般法人7家），持仓量总计11870.48万股，占流通A股58.21%
其中，基金持仓与2023-12-31相比：
增仓：22家 ，增持 1030.62万股
减仓：13家 ，减持 310.49万股
新出现在主力名单中：63家 ，持有2601.09万股
从主力名单中消失：93家 ，原持有3905.44万股
其中，基金持仓与2023-12-31相比：
增仓：22家 ，增持 1030.62万股
减仓：13家 ，减持 310.49万股
新出现在主力名单中：63家 ，持有2601.09万股
从主力名单中消失：93家 ，原持有3905.44万股
消息面诊股
诊断结果：5.9消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 药康生物：11月20日获融资买入320.61万元，
2024-11-21 - 药康生物：11月19日获融资买入228.74万元，
2024-11-20 - 券商观点|医药生物行业跟踪周报：DRG/DIP2.
2024-11-18 - 药康生物：11月13日融券卖出金额8610.00元
2024-11-14 - 药康生物：11月12日获融资买入789.77万元
2024-11-13 - 药康生物：11月11日获融资买入767.24万元，
2024-11-12 - 券商观点|医药生物2024年三季报综述：坚守院内，
2024-11-11 - 【华创医药】医药行业2025年度投资策略：守得云开
2024-11-11 - 药康生物：11月8日获融资买入2375.23万元，
2024-11-11 - 药康生物：首次回购股份70000股
2024-11-08
消息列表
| 一般消息 | 募资投向 | 2024-09-25 | |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-08-29 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2024-08-29 |
| 利好 | 分红转增 | 10派1.6元(含税) | 2024-04-27 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.9行业面打败了21%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.21","price":"0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.66","value":"2.72"},{"date":"2024.11.19","price":"0.67","value":"2.39"},{"date":"2024.11.18","price":"-0.21","value":"-3.50"},{"date":"2024.11.15","price":"-1.45","value":"-3.11"},{"date":"2024.11.14","price":"-1.73","value":"-3.97"},{"date":"2024.11.13","price":"0.51","value":"-1.49"},{"date":"2024.11.12","price":"-1.39","value":"1.61"},{"date":"2024.11.11","price":"0.51","value":"2.97"},{"date":"2024.11.08","price":"-0.53","value":"0.47"},{"date":"2024.11.07","price":"2.57","value":"2.80"},{"date":"2024.11.06","price":"-0.09","value":"0.63"},{"date":"2024.11.05","price":"2.32","value":"3.90"},{"date":"2024.11.04","price":"1.17","value":"2.62"},{"date":"2024.11.01","price":"-0.24","value":"-2.50"},{"date":"2024.10.31","price":"0.42","value":"0.69"},{"date":"2024.10.30","price":"-0.61","value":"-2.07"},{"date":"2024.10.29","price":"-1.08","value":"-2.51"},{"date":"2024.10.28","price":"0.68","value":"2.57"},{"date":"2024.10.25","price":"0.59","value":"4.70"},{"date":"2024.10.24","price":"-0.68","value":"-0.70"}]
上证指数,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 奥浦迈 | 33.94% | 0.02% | 5.3分 |
| 2 | 皓宸医疗 | 31.03% | -12.64% | 5.3分 |
| 3 | 毕得医药 | 30.39% | 3.93% | 5.1分 |
| 4 | 美年健康 | 28.64% | 4.70% | 6.5分 |
| 5 | 普瑞眼科 | 20.99% | -10.26% | 4.9分 |
| 6 | 创新医疗 | 18.19% | -9.24% | 4.8分 |
| 8 | 博腾股份 | 16.11% | -6.05% | 3.5分 |
| 10 | 澳洋健康 | 13.59% | 2.52% | 5.6分 |
| 12 | 诺思格 | 11.26% | -2.23% | 5.6分 |
| 14 | 和元生物 | 10.34% | -4.95% | 4.6分 |
| 16 | 贝瑞基因 | 9.88% | 3.38% | 5.8分 |
| 18 | 诺禾致源 | 9.18% | 0.97% | 5.4分 |
| 20 | 光正眼科 | 8.79% | -4.75% | 5.1分 |
| 22 | 新里程 | 8.66% | -2.13% | 4.9分 |
| 24 | 皓元医药 | 6.64% | -7.50% | 4.7分 |
| 26 | 药康生物 | 6.11% | 0.15% | 4.9分 |
| 28 | 何氏眼科 | 4.65% | -3.28% | 4.4分 |
| 30 | 九洲药业 | 4.47% | 0.45% | 4.5分 |
| 32 | 药明康德 | 4.05% | -4.10% | 4.6分 |
| 34 | 华厦眼科 | 3.50% | -4.70% | 4.8分 |
| 36 | 博济医药 | 1.54% | -0.22% | 5.3分 |
| 38 | 阳光诺和 | 1.30% | -4.83% | 5.2分 |
| 40 | 泓博医药 | 0.31% | -3.34% | 5.2分 |
| 42 | 睿智医药 | 0.15% | -0.15% | 5.0分 |
| 44 | 万邦医药 | -0.60% | -0.90% | 5.5分 |
| 46 | 兰卫医学 | -1.48% | 2.01% | 5.4分 |
| 48 | 成都先导 | -2.24% | -8.12% | 4.2分 |
| 50 | 泰格医药 | -2.74% | 0.12% | 6.1分 |
| 52 | 百花医药 | -3.86% | -2.30% | 4.5分 |
| 54 | - | - | 153.01% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 18/96 ， 3/96。
[{"date":"2024-09-30","value":"4.62","vol":"3.45"},{"date":"2024-06-30","value":"3.60","vol":"2.65"},{"date":"2024-03-31","value":"1.39","vol":"1.13"},{"date":"2023-12-31","value":"7.75","vol":"4.72"},{"date":"2023-09-30","value":"5.80","vol":"6.22"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.62 | 3.60 | 1.39 | 7.75 | 5.80 |
| 行业(%) | 3.45 | 2.65 | 1.13 | 4.72 | 6.22 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"63.65","vol":"36.79"},{"date":"2024-06-30","value":"64.52","vol":"36.95"},{"date":"2024-03-31","value":"65.99","vol":"36.12"},{"date":"2023-12-31","value":"67.61","vol":"39.51"},{"date":"2023-09-30","value":"69.14","vol":"40.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
63.65 | 64.52 | 65.99 | 67.61 | 69.14 |
| 行业(%) | 36.79 | 36.95 | 36.12 | 39.51 | 40.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 10/96 ， 21/96。
[{"date":"2024-09-30","value":"12.13","vol":"2.30"},{"date":"2024-06-30","value":"15.05","vol":"2.66"},{"date":"2024-03-31","value":"11.96","vol":"4.69"},{"date":"2023-12-31","value":"20.45","vol":"10.34"},{"date":"2023-09-30","value":"17.68","vol":"9.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
12.13 | 15.05 | 11.96 | 20.45 | 17.68 |
| 行业(%) | 2.30 | 2.66 | 4.69 | 10.34 | 9.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-16.57","vol":"-152.72"},{"date":"2024-06-30","value":"-1.59","vol":"-97.56"},{"date":"2024-03-31","value":"-5.06","vol":"-46.85"},{"date":"2023-12-31","value":"-3.49","vol":"0.01"},{"date":"2023-09-30","value":"-8.13","vol":"-386.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-16.57 | -1.59 | -5.06 | -3.49 | -8.13 |
| 行业(%) | -152.72 | -97.56 | -46.85 | 0.01 | -386.50 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/96 ， 28/96。
[{"date":"2024-09-30","value":"0.20","vol":"0.31"},{"date":"2024-06-30","value":"0.13","vol":"0.20"},{"date":"2024-03-31","value":"0.06","vol":"0.10"},{"date":"2023-12-31","value":"0.26","vol":"0.43"},{"date":"2023-09-30","value":"0.19","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.13 | 0.06 | 0.26 | 0.19 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.43 | 0.32 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"3.53","vol":"13.99"},{"date":"2024-06-30","value":"2.40","vol":"8.71"},{"date":"2024-03-31","value":"1.05","vol":"4.51"},{"date":"2023-12-31","value":"4.17","vol":"19.08"},{"date":"2023-09-30","value":"2.76","vol":"11.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.53 | 2.40 | 1.05 | 4.17 | 2.76 |
| 行业(次) | 13.99 | 8.71 | 4.51 | 19.08 | 11.28 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"16.34","vol":"12.31"},{"date":"2024-06-30","value":"4.93","vol":"10.34"},{"date":"2024-03-31","value":"-33.49","vol":"0.77"},{"date":"2023-12-31","value":"47.38","vol":"24.44"},{"date":"2023-09-30","value":"6.89","vol":"16.37"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 16.34 | 4.93 | -33.49 | 47.38 | 6.89 |
| 行业 | 12.31 | 10.34 | 0.77 | 24.44 | 16.37 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.52","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"3.31","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.52 | - | 3.31 | - |
| 行业 | 0.00 | 1.47 | 0.00 | 2.51 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/96 ， 42/96。
[{"date":"2024-09-30","value":"4.91","vol":"4.06"},{"date":"2024-06-30","value":"4.09","vol":"4.09"},{"date":"2024-03-31","value":"4.84","vol":"4.35"},{"date":"2023-12-31","value":"4.52","vol":"4.20"},{"date":"2023-09-30","value":"5.29","vol":"4.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.91 | 4.09 | 4.84 | 4.52 | 5.29 |
| 行业 | 4.06 | 4.09 | 4.35 | 4.20 | 4.21 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.23","vol":"3.34"},{"date":"2024-06-30","value":"3.60","vol":"3.35"},{"date":"2024-03-31","value":"4.26","vol":"3.57"},{"date":"2023-12-31","value":"4.02","vol":"3.49"},{"date":"2023-09-30","value":"4.80","vol":"3.65"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.23 | 3.60 | 4.26 | 4.02 | 4.80 |
| 行业 | 3.34 | 3.35 | 3.57 | 3.49 | 3.65 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/96 ， 44/96。
[{"date":"2024-09-30","value":"16.19","vol":"31.14"},{"date":"2024-06-30","value":"19.16","vol":"31.74"},{"date":"2024-03-31","value":"16.73","vol":"31.10"},{"date":"2023-12-31","value":"17.57","vol":"32.13"},{"date":"2023-09-30","value":"15.95","vol":"30.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.19 | 19.16 | 16.73 | 17.57 | 15.95 |
| 行业(%) | 31.14 | 31.74 | 31.10 | 32.13 | 30.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.19","vol":"0.84"},{"date":"2024-06-30","value":"0.24","vol":"0.86"},{"date":"2024-03-31","value":"0.20","vol":"0.91"},{"date":"2023-12-31","value":"0.21","vol":"1.05"},{"date":"2023-09-30","value":"0.19","vol":"1.70"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.24 | 0.20 | 0.21 | 0.19 |
| 行业(%) | 0.84 | 0.86 | 0.91 | 1.05 | 1.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2024-11-12 | 增持 | |
| 国元证券 | 2024-11-07 | 买入 | 买入 |
| 野村东方国际证券 | 2024-11-04 | 中性 | 增持 |
| 华安证券 | 2024-11-04 | 买入 | |
| 开源证券 | 2024-11-03 | 买入 | 买入 |
| 广发证券 | 2024-11-01 | 买入 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"0.76","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.25","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.65","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.59","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.63","blueLineValue":"0.40","type":"YC"}]